NO20085000L - Salter og krystallmodifikasjoner derav - Google Patents
Salter og krystallmodifikasjoner deravInfo
- Publication number
- NO20085000L NO20085000L NO20085000A NO20085000A NO20085000L NO 20085000 L NO20085000 L NO 20085000L NO 20085000 A NO20085000 A NO 20085000A NO 20085000 A NO20085000 A NO 20085000A NO 20085000 L NO20085000 L NO 20085000L
- Authority
- NO
- Norway
- Prior art keywords
- salts
- crystal modifications
- phenyl
- crystalline forms
- crystal
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000013078 crystal Substances 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80283606P | 2006-05-23 | 2006-05-23 | |
| PCT/US2007/069327 WO2007140154A2 (fr) | 2006-05-23 | 2007-05-21 | Sels et leurs modifications cristallines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20085000L true NO20085000L (no) | 2008-12-23 |
Family
ID=38704747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20085000A NO20085000L (no) | 2006-05-23 | 2008-11-28 | Salter og krystallmodifikasjoner derav |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7977330B2 (fr) |
| EP (1) | EP2029556B1 (fr) |
| JP (2) | JP2009538330A (fr) |
| KR (1) | KR20090009898A (fr) |
| CN (1) | CN101448796B (fr) |
| AR (1) | AR061056A1 (fr) |
| AT (1) | ATE486858T1 (fr) |
| AU (1) | AU2007267671A1 (fr) |
| BR (1) | BRPI0712556A2 (fr) |
| CA (1) | CA2650514A1 (fr) |
| CL (1) | CL2007001454A1 (fr) |
| CR (1) | CR10431A (fr) |
| DE (1) | DE602007010286D1 (fr) |
| EC (1) | ECSP088900A (fr) |
| ES (1) | ES2355166T3 (fr) |
| GT (1) | GT200800253A (fr) |
| IL (1) | IL195008A0 (fr) |
| MA (1) | MA30482B1 (fr) |
| MX (1) | MX2008014836A (fr) |
| NO (1) | NO20085000L (fr) |
| PE (1) | PE20080261A1 (fr) |
| PL (1) | PL2029556T3 (fr) |
| PT (1) | PT2029556E (fr) |
| RU (1) | RU2008150627A (fr) |
| TN (1) | TNSN08477A1 (fr) |
| TW (1) | TW200815375A (fr) |
| WO (1) | WO2007140154A2 (fr) |
| ZA (1) | ZA200809096B (fr) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ538870A (en) * | 2002-09-20 | 2007-04-27 | Arrow Therapeutics Ltd | Benzodiazepine derivatives and pharmaceutical compositions containing them |
-
2007
- 2007-05-21 AU AU2007267671A patent/AU2007267671A1/en not_active Abandoned
- 2007-05-21 PL PL07797606T patent/PL2029556T3/pl unknown
- 2007-05-21 AT AT07797606T patent/ATE486858T1/de active
- 2007-05-21 RU RU2008150627/04A patent/RU2008150627A/ru not_active Application Discontinuation
- 2007-05-21 US US12/298,203 patent/US7977330B2/en not_active Expired - Fee Related
- 2007-05-21 PT PT07797606T patent/PT2029556E/pt unknown
- 2007-05-21 ES ES07797606T patent/ES2355166T3/es active Active
- 2007-05-21 JP JP2009512241A patent/JP2009538330A/ja active Pending
- 2007-05-21 MX MX2008014836A patent/MX2008014836A/es not_active Application Discontinuation
- 2007-05-21 DE DE602007010286T patent/DE602007010286D1/de active Active
- 2007-05-21 AR ARP070102191A patent/AR061056A1/es unknown
- 2007-05-21 EP EP07797606A patent/EP2029556B1/fr active Active
- 2007-05-21 WO PCT/US2007/069327 patent/WO2007140154A2/fr not_active Ceased
- 2007-05-21 BR BRPI0712556-9A patent/BRPI0712556A2/pt not_active Application Discontinuation
- 2007-05-21 KR KR1020087028592A patent/KR20090009898A/ko not_active Ceased
- 2007-05-21 CN CN2007800181255A patent/CN101448796B/zh not_active Expired - Fee Related
- 2007-05-21 CA CA002650514A patent/CA2650514A1/fr not_active Abandoned
- 2007-05-21 PE PE2007000619A patent/PE20080261A1/es not_active Application Discontinuation
- 2007-05-22 TW TW096118228A patent/TW200815375A/zh unknown
- 2007-05-22 CL CL200701454A patent/CL2007001454A1/es unknown
-
2008
- 2008-10-23 ZA ZA200809096A patent/ZA200809096B/xx unknown
- 2008-10-30 IL IL195008A patent/IL195008A0/en unknown
- 2008-11-10 CR CR10431A patent/CR10431A/es not_active Application Discontinuation
- 2008-11-21 GT GT200800253A patent/GT200800253A/es unknown
- 2008-11-21 EC EC2008008900A patent/ECSP088900A/es unknown
- 2008-11-21 TN TNP2008000477A patent/TNSN08477A1/en unknown
- 2008-11-26 MA MA31419A patent/MA30482B1/fr unknown
- 2008-11-28 NO NO20085000A patent/NO20085000L/no not_active Application Discontinuation
-
2013
- 2013-01-04 JP JP2013000196A patent/JP2013075910A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2650514A1 (fr) | 2007-12-06 |
| KR20090009898A (ko) | 2009-01-23 |
| MX2008014836A (es) | 2008-12-01 |
| WO2007140154A3 (fr) | 2008-03-20 |
| ATE486858T1 (de) | 2010-11-15 |
| US7977330B2 (en) | 2011-07-12 |
| EP2029556A2 (fr) | 2009-03-04 |
| MA30482B1 (fr) | 2009-06-01 |
| PL2029556T3 (pl) | 2011-04-29 |
| DE602007010286D1 (de) | 2010-12-16 |
| CL2007001454A1 (es) | 2008-05-16 |
| PE20080261A1 (es) | 2008-04-18 |
| ZA200809096B (en) | 2009-11-25 |
| ES2355166T3 (es) | 2011-03-23 |
| IL195008A0 (en) | 2009-08-03 |
| AU2007267671A1 (en) | 2007-12-06 |
| CN101448796B (zh) | 2012-09-26 |
| AR061056A1 (es) | 2008-07-30 |
| PT2029556E (pt) | 2011-01-31 |
| JP2013075910A (ja) | 2013-04-25 |
| JP2009538330A (ja) | 2009-11-05 |
| TW200815375A (en) | 2008-04-01 |
| WO2007140154A2 (fr) | 2007-12-06 |
| CR10431A (es) | 2009-01-07 |
| CN101448796A (zh) | 2009-06-03 |
| US20090163478A1 (en) | 2009-06-25 |
| RU2008150627A (ru) | 2010-06-27 |
| EP2029556B1 (fr) | 2010-11-03 |
| ECSP088900A (es) | 2008-12-30 |
| TNSN08477A1 (en) | 2010-04-14 |
| GT200800253A (es) | 2009-04-29 |
| BRPI0712556A2 (pt) | 2013-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200500203A1 (ru) | Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат | |
| MY155230A (en) | Sulfoximine-substituted aniline pyrimidine derivatives as cdk inhibitors, their manufacture and use as medicine | |
| NO20076658L (no) | Heteroarylbenzamidderivater for anvendelse som GLK aktivatorer ved behandling av diabetes | |
| NO20023786D0 (no) | Heteroaromatiske karboksamidderivater og deres anvendelse som inhibitorer av enzymet IKK-2 | |
| NO20082482L (no) | Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer | |
| HUP0301513A2 (hu) | O-Aril-glükozid SGLT2 inhibitorok és eljárás elżállításukra | |
| NO20090064L (no) | Pyrasoler som glucokinase aktivatorer | |
| TNSN06411A1 (en) | Pyrimidine urea derivatives as kinase inhibitors | |
| UA94390C2 (ru) | Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких | |
| NO20082395L (no) | Krystallinske former av 1'-(1-metyl)-4'-[(2-fluor-4-metoksyfenyl)metyl]-5'-metyl-1H-pyrazol-3'-O-beta-D-glucopyranosid, en fremstillingsmetode og anvendelse av denne for fremstilling av medikamenter | |
| IS7638A (is) | Asabísýkló-oktan- og nónanafleiður með DDP-IV tálmunarvirkni | |
| NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
| BR0015836A (pt) | Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp | |
| NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
| DK1517890T3 (da) | Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
| ATE347555T1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
| NO20083068L (no) | Optisk aktive karbamater, fremgangsmate for deres fremstilling og anvendelse derav som farmasoytiske mellomprodukter | |
| NO20070089L (no) | DPP-IV inhibitorer | |
| NO20082214L (no) | 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer | |
| DE502005008057D1 (de) | Substituierte cyclopenten-verbindungen | |
| NO20053810L (no) | Thiofenkarboksamider som inhibitorer av enzymet IKK-2 | |
| NO20084177L (no) | Substituerte Imidazo[2,1-B]thiazolforbindelser og deres anvendelse for produksjon av legemidler | |
| BR0312593A (pt) | Aciluréias substituìdas por uréia e uretano, processo para a sua produção e sua aplicação | |
| PL1888514T3 (pl) | Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych | |
| NO20085000L (no) | Salter og krystallmodifikasjoner derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |